Pr Morgan Rouprêt
- Spécialité
- Oncologue médical, expert urologie
- Hôpital
- AP-HP Hôpital Pitié Salpêtrière (Paris)
- Derniers articles
-
- Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results. (11 janv. 2025)
- Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines. (7 janv. 2025)
- How To Write a Response to Reviewers. (6 janv. 2025)
- The Financial Burden of Localized and Metastatic Bladder Cancer. (26 déc. 2024)
- Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation. (19 déc. 2024)